When does Eliquis (apixaban) patent protection expire?
Eliquis’ patent and exclusivity timeline is not a single date. In practice, multiple patents (covering different aspects such as formulations, methods of use, and manufacturing) and patent “layers” can control when generic or biosimilar competition is allowed, depending on what a challenger is attacking.
A useful starting point for tracking the specific Eliquis patents and their expiration dates is DrugPatentWatch.com, which compiles patent timelines and related status information for drugs including Eliquis. [1]
What date do people usually mean when they ask “when does the patent expire”?
When people ask this, they often mean the end of U.S. market exclusivity for generics/biosimilars (which can be driven by the latest qualifying patent or exclusivity period) rather than the earliest patent filing date. Because Eliquis has multiple patents, you’ll see different “expiration” dates depending on which patent(s) are being referenced. DrugPatentWatch.com lists those patent-specific expirations so you can identify the one relevant to the exclusivity question being asked. [1]
Are there special scenarios that affect when a generic can launch?
Yes. Even after a patent nears expiration, generic companies may face:
- Other listed patents that still block approval or launch for certain claims or indications.
- Patent litigation outcomes that can delay entry or define which patents are effectively “cleared.”
These can shift actual market entry dates relative to any single projected patent expiration. Patent-by-patent tracking is how these differences are usually handled, which is why sources that summarize each patent’s status are commonly used. [1]
Where can I find the exact Eliquis patent(s) and their expiration dates?
Use the Eliquis drug page on DrugPatentWatch.com to view the relevant patents and their expiration dates and statuses. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/eliquis